Pan, M., Wang, D., Xu, J., Jin, S., Wang, Y., Tao, Y., Liu, Y., Ouyang, W., Weng, X., Yi, H., Huang, Y., Cao, X., Li, S., Zhang, F., Zhang, W., Li, C., Mi, J. (2026). The fully human anti-GPRC5D CAR T-cell therapy RD118 induces durable remissions in relapsed/refractory multiple myeloma. Blood. https://doi.org/10.1182/blood.2025030559